Endocyte Inc (NASDAQ:ECYT) - Share price - Overview

Stock Report

Endocyte Inc ECYT

Last Price
$2.42

Day Change
0.09|3.86%

As of 29/03/2017
16:00:00 EDT | USD
Minimum 15 Minutes Delay.

Last Close2.33
Day Range2.31 - 2.46
Mkt Cap102.80Mil
52-Wk Range1.98 - 4.33
Yield %-
ISINUS29269A1025
Volume218,731
P/E-2.33
P/S1,428.57
P/CF-2.95

Share Price

Financials
201420152016
More ...
Income Statement
Revenue70.350.070.07
Operating Income5.03-41.97-44.72
Net Income5.46-41.27-43.89
Basic EPS0.14-0.98-1.04
Avg. Diluted Shares Outstanding424242
Balance Sheet
Current Assets127.04174.88140.26
Non Current Assets85.763.513.24
Total Assets212.80178.39143.49
Current Liabilities6.886.195.56
Total Liabilities7.807.046.35
Total Equity205.00171.35137.15
Cash Flow
Operating Cash Flow-42.21-32.22-34.65
Capital Expenditure-1.50-0.34-0.71
Free Cash Flow-43.71-32.56-35.36

In millions, except "Basic EPS". Currency is USD.

Company Profile

Endocyte Inc is a biopharmaceutical company. The Company is engaged in developing targeted therapies for the treatment of cancer and inflammatory diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

76
Key Stats
More ...
Price/Earning TTM-2.24
Price/Book0.72
Price/Sales TTM1,370.59
Rev Growth (3 year avg)-89.74
EPS Growth (3 year avg)-
Operating Margin % TTM-63,886.18
Net Margin % TTM-62,696.53
ROE TTM-28.45
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.